Cargando…
Comparison of clinical results of two pharmaceutical products of riboflavin in corneal collagen cross-linking for keratoconus
BACKGROUND: To compare the 6-month results of two formulations of Riboflavin provided by Sina Darou, Iran, and Uznach, Switzerland, in corneal collagen cross-linking (CXL) for keratoconus patients. FINDINGS: Considering the results of the previous study about the similarity of the formulations and t...
Autores principales: | Hashemi, Hassan, Seyedian, Mohammad Amin, Miraftab, Mohammad, Bahrmandy, Hooman, Sabzevari, Araz, Asgari, Soheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001359/ https://www.ncbi.nlm.nih.gov/pubmed/24713424 http://dx.doi.org/10.1186/2008-2231-22-37 |
Ejemplares similares
-
Clinical results with two different pharmaceutical preparations of riboflavin in corneal cross-linking: an 18-month follow up
por: Hashemi, Hassan, et al.
Publicado: (2015) -
Corneal Collagen Cross-Linking in the Treatment of Progressive Keratoconus: A Randomized Controlled Contralateral Eye Study
por: Seyedian, Mohammad A., et al.
Publicado: (2015) -
Multipoint assessment of demarcation line depth after standard and accelerated cross-linking in central and inferior keratoconus
por: Asgari, Soheila, et al.
Publicado: (2018) -
Mesopic Quality of Vision after Accelerated 18 mW/cm(2) Corneal Cross-linking: Mid-term Results
por: Hashemi, Hassan, et al.
Publicado: (2017) -
Comment on: Corneal collagen cross-linking with riboflavin and ultraviolet: A light for keratoconus
por: Parthasarathy, Anand
Publicado: (2010)